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In a  multiceilular culture and probably in a  single cell,  the production of 
virus which  follows infection represents a  continuous process with  many of 
the  stages  of development proceeding at  the  same  time  (1-3).  Even when 
dealing with a  single sequence of infection (3, 4), it is difficult to learn of the 
interdependence and order in which reactions occur. The possibility of syn- 
chronizing the viral synthetic process by the use of phase-specific inhibitors 
has been explored in the past  (5). In the present experiments, the technique 
is employed to investigate the interrelationship of the function of methionine 
and phenylalanine in  the synthesis of influenza virus. 
p-Fluorophenylalanine antagonizes  the utilization of phenylalanine  and by virtue 
of this it shows potent anfiviral activity in cultures  producing  either poliomyelitis 
virus  (4),  or the agent from Sendai,  mentioned in reference 6. The evidence from 
other biological systems  suggests  that the fluoroderivafive  prevents the participa- 
tion of phenylalanine in the synthesis of protein (7). 
Several structural  analogues  of mekkionine have been found which  will  inhabit 
the multiplication  of influenza virus.  However, methionine  is known to be involved 
in many biological processes and it is unlikely  that the various  metabolic  antago- 
nists  of methionine  interfere with  the same  process  (8).  The inhibitory action of 
methoxinine  and ethionine  can be reversed  by methionine  (9), but that of methio- 
nine sulfoximine can not. Apparently, this latter structural analogue is not a meta- 
bolic  analogue  of  methionine.  The  inhibition  of  influenza  virus  induced  by 
this substance is reversed  by glutamine,  but not by glutamie  acid  or methionine 
(10). 
The site of action of methoxinine in the infectious sequence has been most studied 
and  has  been defined  relative to  the  effects produced by the receptor-destroying 
enzyme  (from  cholera  vibrio)  and ~-amino-p-methoxyphenyknet~ne  sutfonic  acid 
(5). Ii1 the present study the phase specmcity of me~oxinine is used as a metabolic 
marker  to  describe  the  relative  site  of  action  of  p-~uoropheny|alanine.  It  win  be 
shown that like methoxinine, p-nuorophenylalanine is phase-speciOc,  does not inter- 
fere  with the initiation  of infection, but rather acts during the productive period of 
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the  infectious sequence. The  two  inhibitors act upon different reactions which for- 
the  most  part  occur  simultaneously but  are  closely  interdependent. It  has  been 
possible to define two developmental stages which could not be recognized from the 
usual growth curve. 
Materials and Methods 
Virus and Tissue.--In all experiments of this study, the PR8 strain of Type A influenza 
virus was used. It has undergone 7 passages in ferrets, 593 passages in mice, and 141 passages 
in eggs. The host tissue was obtained from the chorioallantoic membrane of 14- to 16-day-old 
embryonate eggs. 
dl-Methoxlnine.--(dl-c~-amino-T-methoxbutyric acid) was  generously  supplied  by  the 
American Cyanamid Company. 
dl-Fluoropl~nylalanine.--(FPA)  x was kindly supplied by Dr. Marvin D. Armstrong at the 
University of Utah. 
Immune Serum.--The immune serum was obtained from ferrets which had received by 
intranasai instillation ailantoic fluid containing the PR8 strain of influenza virus. The hemag- 
ghitination-inhibition titer was 4096. 
Receptor-Destroying Enzyme (RDE) * was a partially purified preparation of cholera vibrio 
extract  obtained  from the allantoic  inoculation of embryonate  eggs. It contains approxi- 
mately 32,000 units of receptor-destroying enzyme per rag. of nitrogen. 
Warburg Flask C~dture.--A detailed description of the method has been given elsewhere 
and details of individual experiments will be found in the experimental section (9, 11). As 
routine the host-virus system was maintained in a Waxburg apparatus  using as medium a 
modified Simms  solution. The center-well contained Pardee's mixture. The reaction chamber 
of the vessel contained 400 nag. of chorioallantoic membrane that was used without mincing. 
The cultures were incubated with shaking at 37°C. 
Virus Titratimts.--The  amount of virus was estimated by determining the infectious titer 
for eggs. For this purpose, tenfold serial dilutions were prepared in broth, and four to six eggs 
were inoculated with 0.1 mL of each dilution. After 3 days of incubation  at 37°C, a sample of 
allantoic fluid was removed from each egg and tested for virus by the addition of red blood 
cells. The 50 per cent infectious titer was calculated by the method of Reed and Muench (12). 
The titers expressed in the paper represent the number of 50 per cent egg infectious doses 
per 0.1 ml. of sample. 
EXPF.I~TM~NTAL AND  RESULTS 
Relation of the Age of Infection  to  the Inhibitory Effectiveness  of FPA  and 
Methoxinine.--A number of inhibitors of viral production have been found to 
be  not only metabolically specific but also  phase-specific.  When such  com- 
pounds are added  to a  culture in which a  single sequence of infection is oc- 
curring, the  ability of the  compound to  inhibit virus increase depends upon 
what portion of the sequence has occurred; i.e., upon the age of the infection. 
This implies the presence of discrete phases in the synthesis of virus. Meth- 
oxinine is such a  phase-specific inhibitor. While being inhibitory, it does not 
affect the initiation of infection, those functions for which the RDE-sensitive 
1 FPA, p-fluorophenylalanine. 
2 RDE, receptor-destroying enzyme from a partially purified preparation of cholera vibrio 
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receptors  are  required,  the  process  inhibited  by  a-amino-p-methoxyphenyl- 
methanesulfonic  acid,  the  last  stages of viral maturation  nor  the  release  of 
newly formed virus  (4).  To  determine  the site  of  action  of  p-fluorophenyl- 
alanine  (FPA)  and to test its phase-specificity, it was  studied in conjunction 
with  methoxinine  whose  influence  at  a  distinct phase  of virus  development 
was well identified. 
To  do  this,  methoxinine  and  FPA  were  added  separately to  parallel cul- 
tures in which a  single sequence of infection was induced with a  massive viral 
inoculum. By adding the inhibitors to cultures at various times after infection 
and determining the per cent inhibition which could be obtained, it was pos- 
sible to determine whether  the reactions inhibited by FPA and methoxinine 
were  occurring at nearly the  same stage of the  growth  sequence. 
Replicate cultures were prepared in Warburg vessels with a  modified Simm.g medium in 
the reaction chamber and Pardee's mixture in the center-well.  Each flask contained 400 
rag. of chorioallantoic  membrane and 0.3 ml. of undiluted allantoie fluid infected with niP 
proximately 109-0 EIDso per 0.1 ml. After 1 hour of incubation with shaking at 37"C., the 
tissues were removed, washed six times in cold saline, one time in immune serum, and trans- 
ferred to a second culture flask containing only Simms's medium.  Several of the above cul- 
tures, which comprised one series, received a single addition of 0.3 rag. of FPA at some inter- 
val between 0 and 7 hours. When the additions were made at 0 hour or 1 hour after virus, 
they were added necessarily to the first flask in which the infection was initiated. Then the 
membranes were transferred to a second flask which already contained FPA and in which 
the production of virus was followed. 
The fluid portions of the cultures were all sampled at 2 hours, at the time FPA was added, 
at 12 hours and at 24 hours. From these observations it was possible to determine the viral 
increase which occurred before the addition of FPA and also afterward. The per cent inhi- 
bition which ensued upon each addition of FPA was calculated from the actual increase ob- 
served by the 12th hour and the maximal increase of virus possible as determined by the 
titer of virus at the time of addition of the inhibitor and the titer of the control culture at 
the 12th hour. 
In a second series d/-methoxin;ne  was added to the cultures in the same manner as de- 
scribed for FPA. The additions of methoxinine were 4.0 rag. per flask. 
The  resulting  data  from  both  series are  tabulated  in  Table  I.  It  will be 
noted  that the amount of each inhibitor used was sufficient to produce com- 
plete  inhibition  when  added  at  the  same  time  as  the  virus  and  retained 
throughout  the  incubation  period.  Both  compounds  became  less  effective 
when  added later in the infectious sequence until finally by the 7th hour no 
inhibitory effect  was  evident.  When  added  progressively later  in  the  infec- 
tious sequence,  there was some indication that methoxinine became less effec- 
tive at a  greater rate than FPA. By the 4th hour, methoxinine would produce 
only partial inhibition while FPA was almost completely effective. This sug- 
gests that the two analogues act upon different phases of development which 
occur close upon each other.  The one  sensitive to methoxinine may be com- 
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periods of sensitivity and resistance is probably due to  the  lack of  synchro- 
nization of the synthetic centers and has been discussed previously (5).  From 
these data one cannot tell the order in which the sensitive phases begin and it 
is there that the two should be most clearly distinguished. This point will be 
considered next by a  different type of analyses. 
TABLE I 
Rdation of Inhibiting Capacity of FPA and Metkoxlnine to Age of Infection 
Time of adding 
inhibitor 
Viral titers* of cultures 
At time  of adding  at 2 hrs.  inhibitor  At 12 hrs.  At 24 hrs. 
~Fluoropheny]~!~nine§ 0.1 mg./ml. 
Per cents 
inhibition at 
12th hr. 
None 
0 
i 
2 
3 
4 
5 
6 
7 
3.4 
3.0 
3.9 
3.8 
3.3 
3.5 
3.5 
3.1 
3.1 
i 
m 
3.8 
4.3 
4.7 
5.0 
6.4 
7.3 
8.9 
3.0 
3.9 
3.6 
4.5 
5.0 
6.4 
7.6 
8.8 
9.2 
3.3 
4.4 
4.5 
4.5 
5.5 
6.8 
8.4 
9.4 
m 
100 
100 
104 
98 
93 
64 
52 
0.6 
d/-Methox'inlne[[ 1.3 mg./ml. 
None 
0 
4 
5 
6 
7 
3.3 
3.0 
3.5 
3.3 
3.3 
3.3 
3.0 
4.3 
5.3 
6.4 
7.3 
8.8 
2.7 
5.5 
7.0 
8.1 
8.9 
9.4 
3.0 
6.7 
7.9 
8.8 
9.4 
100 
73 
51 
29 
0 
* Viral titers expressed as --log of the infectious  fiter for eggs. 
Per cent inhibition calculated: control titer at 12th  hour---titer of trcated culture at 
12th hour/control titer at 12th houx'--titer of treated culture at time of addition of inhibitor. 
§ These data axe a composite of four closely comparable experiments. 
[[ These data, are taken from two closely comparable experiments. 
Increase  of Extracellular  Virus  Following  Virostasis  Induced  witk FPA.-- 
When an infected culture of cells is inhibited by a  reversible inhibitor and the 
inhibition is maintained for several hours,  much of the individual differences 
in the response of cells to virus can be reduced and the sequence of infection 
synchronized.  Though  some  ceils  may  have  become  infected  earlier  than 
others  and  the  development  of  virus  begun  sooner  or  is  proceeding  more 
rapidly in some, during the period of virosta,sis an opportunity is had for the 
infection in all ceils to proceed to the same stage of development at which it 
is arrested and  there  to  await  the  reversal of inhibition for further  matura- W.  WILBUR  ACKERMANN  AND  HUIVEIN  ~'.  MAASSAB  397 
tion. When the inhibition is relieved, development proceeds as if all centers 
of synthetic activity were at the same metabolic point. If virostasis is induced 
by different inhibitors which act upon phases which begin at different times 
in the infectious sequence, development in one case may proceed further dur- 
ing virostasis than in another. Upon release of the inhibition, the difference 
may be manifest in the growth curve as is shown in the following experiments 
using methoxinine and FPA. 
Two cultures were prepared in the usual manner with 400 nag. of chorioailantoic mem- 
brane and Simms's solution. Each received 0.3 nag. of FPA and 0.3 ml. of allantoic fluid which 
f 
~8 
7  J  vmus or 
]  ExT~ct-uJ~  rLu,o 
t,.  ~ P'-F'LUOROPH~NYLALA  N I N I~ 
;o  : ......  -  !  ...... 
 2|f  T  I  i"  rPA  FP~A  R~ RDE  PA 
v,~us,  Wp.  .......... 
2  4  6  8  I0  12  u~24 
TIME  IN  HOURS 
FIG.  1. The tissues were exposed to virus (3 X  l(P  ~ EIDs0)  in the presence of 0.l nag. of 
FPA  ~-fluorophenylaianine) for  1 hour at  37°C.  after which 0.2  ml.  of RDE  (receptor- 
destroying-enzyme) was added. The tissues were washed at 2 hours in saline and  added to a 
second flask conta;ning FPA and RDE.  At  the 7th hour, 0.2 nag. of PA  (d/-phenylalanine) 
was added to one of the cultures. 
supplied 10  s'a EID~0 of influenza virus. After 1 hour of incubation 0.2 ml. of a preparation of 
RDE containing 32,000 units of enzyme was added. Incubation was continued for a 2nd hour 
and then the tissues were removed, washed six times with saline, once with immune serum, 
then replaced into culture flasks containing medium, RDE and FPA. To one of these no fur- 
ther additions were made and the extracellular fluid was titrated for virus at 2.3, 7, and 12, 
and 24 hours. The second flask received 0.4 rag. of phenylalanine at the 7th hour. The fluid 
portion of the culture was tested for virus at 2.3, and 7 hours and also at each 0.5 hour in- 
terval following the 7th hour. 
In the normal growth curve an increase in virus is not detectable until 3 
to 4 hours after the addition of the viral inoculum. It will be noted from the 
data plotted in  Fig.  1 that  within 30 minutes or less after the addition of 
phenylalanine, the virus of the fluid had increased 20-fold. Upon release of the 
inhibition, the production of virus proceeds with little or no lag and further 
the rate of production is extremely rapid so that the maximum titer is reached 398  GROWTH  CHARACTERISTICS  O~F  IN~LU'EIq'ZA  VIRUS 
in  3  hours. Apparently,  the  rate-determining  reaction  of the  viral  synthetic 
process  is different  from that which operates normally. This indicates that in 
the usual production of virus the rate-limiting  reaction is in the early rather 
than advanced stages of development. 
It is also apparent that in the presence  of FPA, infection can be initiated 
and  the function of the receptors  sensitive  to  RDE  can be completed.  The 
process  which is inhibited by FPA is not irreversibly  damaged. The inhibition 
can be reversed  by phenylalanine after a  virostatic period of 3,  7,  t0,  or 24 
hours with excellent yields of virus. This is in contrast to the results obtained 
with poliomyelitis virus propagating in HeLa cells  (4). However, it should be 
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FIG.  2. Each point represents the fiter of the tissue and fluid portions of s  separate cul- 
ture. All tissues were exposed to virus (3  X  10  g~ EID~0 in the presence of 0.1  rag.  of FPA 
(fluoropheny]~T~t,i,e)  and subsequently treated with RDE  (receptor-destroying enzyme) PA 
(phenylal~-;-e)  and washed as described under Fig.  1. 
noted that if the virostatic period is 3 hours, production of influenza  virus is 
resumed after a  clearly  detectable  lag.  When  the period of virostasis was 7, 
10, or 12 hours, no lag was discernible. 
In~reas¢ in Total  Virus Folkn~ng  Virosta~is I~utuc~ with FPA.--The sud- 
den increase  of virus in the fluid after release  of the inhibition suggests virus 
had accumulated in the  tissue during the virostatic period.  However,  this is 
apparently not the case as is indicated by the following experiment. 
Seven replicste cultures were prepared as described in the previous section with medium, 
tissue,  virus,  and  FPA.  The addition of RDE  was made to each  culture st the end  of the 
1st hour of incubation.  Each  tissue was incubated  for  1 hour more  and  then washed  with 
saline and immune  serum.  The washed  tissues were  replsced  into vessels cont~;-;ng RDE, 
FPA, and Simms's solution. At 2.3 hours one tissue was removed, ground with alundum and 
titrsted for virus. The virus of the fluid portion of the curve was also estimsted. The remain- 
ing six cultures received at the 7th hour 0.4 nag. of phenylalmfine.  Tissues were removed at W.  WILBUR ACKERMANN  AND  HUN'gIN  lB.  MAASSAB  399 
the 7th hour and at each 0.5 hour interval until the 9th hour. The total vires  of individual 
replicate flasks could be determined from the titration of the corresponding fluid and the 
membrane. The resulting data showing the increase in the total virus as a  function of time 
before and after the addition of phenylalanine are plotted in Fig. 2. 
No  increase  in virus  was observed in  the virostatic period from 2.3  to  7 
hours. Further, within the first half hour after the addition of phenylalanine, 
an increase  in  the  total virus of the  culture could be detected. The results 
closely parallel the observations made of the extracelluiar fluid. Apparently, 
these reactions which must occur in the constant period before there is any 
production of new virus, occur also when fluorophenylalanine is present. 
Vira~ Increase Following Virostasis  Induced  by  Metkoxinine.~Next  the 
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FIo. 3. The data were all obtained by sampling the fluid portion of one culture at various 
times. The experiment was patterned after that described in Fig.  1. MX (methoxlnine) was 
used at a  concentration of 1.3 rag. per ml. and removed by transferring the tissue to a fresh 
culture free of methoxinine. 
effect upon the growth curve of virostasis induced by methoxlnlrte was studied 
in a series of experiments designed after the pattern described for FPA in the 
second section. In the place of FPA, 4.0 rag. per culture of methoxinine was 
used. At the 7th hour the tissue was washed in saline and transferred to  a 
second flask  to  free the tissue  of  metho~in;ne. The appearance of influenza 
virus  in  the  fluid  portion  of  the  culture  was  followed  and  the  results 
are plotted in Fig. 3.  The experiment and results are similar to that experi- 
ment described in a  previous publication (3).  In the present series of experi- 
ments varying periods of virostasis (3,  7,  12 hours) were investigated. 
The findings are in contrast to those obtained with FPA. A constant period 
of at least 2 hours dapsed between the rdease of inhibition and the fLrst de- 
tectable increase in virus tlter. It is apparent that a  considerable amount of 
biochemical  activity,  which  must  occur  during  the  constant period  before 
the production of any new virus, did not occur in the presence of methoxinine. 400  GROWTH  CB.ARACTERISTICS  0]~  INFLU'ENZA  VIRUS 
Again there is  the increased slope of the production portion of the growth 
curve. The two phases  in the viral development which were suggested  by the 
variation in sensitivity of different portions of the infectious  sequence to the 
action  of methoxinine and  FPA  are  more  dearly distinguished.  The  data 
imply that the methoxinine-sensitive  phase begins before the phase which is 
inhibited by FPA. 
Sequential  Action  of  Metkoxinine  and  FPA.--The  interrelation  of  these 
phases of viral development was further illustrated by determining the ca- 
I0 
o'- FPAI  .,, 
O*oPA  |  ,,,,"'..a 
.,'"  ./'/o'-  rpal 
uc  ,f"  /*  17''PA I 
"'  ,/-"/ 
,,,/""  . 
w  •  /"  ,e  e  [ 7"-Pk | 
"  /  /7  ~f---  _z  s  x/ 
I/  /  / 
.  J  ./" 
jf  o  .... ~..,,.~..._~.  .........  .~.-  ...~..__...._._~  oC-~-__  C  pA') 
/o'-  v~2"~"" 
| O'-PA I 
I  I  I  I  I  I  I  I  I  I  I  ~  J  " 
2  4  6  8  I0  I  m 24 
TIM[  IN  HOURS 
Fro. 4. The concentrations employed were: 0.1  rag.  of FPA (p-fluorophenylahnine) per 
nil., 1.3 mg. of MX (methoxinine) per ml., 0.2 rag. of PA  s (dl-phenylalanine) per ml. Theordcrs 
of addition are presented with the corresponding curves. The data presented for each curve 
were obtained by repeated sampling of the fluid portion of one culture. 
pacity of each analogue to inhibit the viral increase which follows the viro- 
static periods induced by FPA and methoxinine. 
Five culture flasks were prepared containing the usual culture medium, 400 rag.  of chick 
membrane, a  massive inoculum (3  X  10  ° EIDs0)  or influenza virus, and 0.3  rag.  of FPA. 
One of the cultures also received 0.4 rag. of phenylalanine while a second was given 0.4 rag. 
of phenylalanine plus 4.0 rag.  of methoxinine. At the end of 1 hour the tissues were washed 
to remove residual inoculum and placed into new vessels with the same contents as those 
in which infection was initiated; however, no virus addition was made. To two of the flasks 
receiving only FPA at 0 time, further additions were made at the 7th hour. One flask received 
0.4 rag.  of phenylalanine and to the second was added both 0.4 rag.  of phenylalanine and 
4.0 nag. of methoxinine. At various intervals from 2 to 12 hours the fluid portions of all cul- 
tures were sampled and titrated for virus. The resulting data will be found in Fig. 4. 
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The flask containing FPA throughout and which received no other addition 
showed no viral increase by 24 hours. Hence, the concentration of FPA used 
was sufficient to prevent viral multiplication when added at 0  time. 
The  culture  receiving  FPA  and  phenylalanine at  0  time showed a  viral 
growth  rate  quite  similar  to  the  usual  untreated  infected membrane.  The 
concentration of phenylalanine employed antagonized completely the  effect 
of FPA. 
When  a  culture  received  FPA,  phenylalanine,  and  methoxinine  at  the 
time of addition of virus, no viral increase was detected by the  24th hour. 
Thus the addition of 4.0 rag. of methoxinine at the time of initiation of in- 
fection and in the presence  of FPA and phenylalanine, i.e.  to a  culture ca- 
pable of supporting viral multiplication, is completely inhibitory. The result 
then can be  compared with that obtained when methoxinine is added  to  a 
similar culture at the 7th hour. 
The fourth culture to which phenylalanine was added at the 7th hour pro- 
duced a substantial viral increase comparable to the culture receiving PA and 
FPA at zero time. However, the rate of viral increase, as also shown in Fig. 1, 
is so rapid that the maximum yield is obtained, after a  virostatic period, at 
nearly the same time as the control. 
The fifth culture received both phenylalanine and methoxinine at the 7th 
hour  and  it  showed a  limited amount of  growth.  Clearly the  methoxinine 
was not a  very effective inhibitor when added after the virostatic period in- 
duced by FPA. The effectiveness of methoxinine was also tested after 10 and 
12  hour  FPA virostatic  periods.  Under  such  conditions the  yields of virus 
were larger  than after the  7th hour period but  did not approach  the viral 
yield of the control. 
In a  similar series of experiments, the inhibitory effect of FPA was tested 
upon a  culture producing virus after a  virostatic condition was imposed for 
7  hours  by  methoxinine.  The  viral  multiplication  which  follows virostasis 
induced by methoxinine could be completely inhibited by FPA. 
DISCUSSION 
The  observations  presented here  are  intelligible if one  assumes that  two 
stages  of viral  development, A  and B,  are  occurring in  the  infected multi- 
cellular culture.  For the  most part  these  occur simultaneously. Reaction A 
begins early in the latent period; it is inhibited by methoxinine but not by 
FPA. Further, it can proceed independent of the second reaction. Reaction B 
is sensitive to the action of FPA but not to that of methoxinine. This reaction 
cannot proceed unless the first reaction is occurring or has operated for some 
prior  interval.  Because of this interdependence,  the  second reaction can be 
indirectly prevented by the addition of metho~nine. The inability of the sys- 
tem to bring reaction A entirely to completion when B  is inoperative (as in- 402  GROWTH  CHARACTERISTICS  OF  I-N'FLUEN'ZA VIRUS 
d/cated by the partial inhibitory effect of methoxinine after virostasis induced 
by FPA) may be similar  to the product-inhibition phenomenon seen in many 
blocked enzymatic reactions in which there is product accumulation. 
It is of interest  to  note  that  by this  technique  it  was possible to isolate 
stages of development which usually occur in multicellular cultures in widely 
overlapping intervals of the infectious sequence. As the list of carefully studied 
inhibitors  grows,  it will  be possible  to map  the viral  synthetic pathway in 
terms of these metabolic markers.  The  technique will be of particular value 
in  the  future  study of  the  problem  by classical  biochemical methods.  For 
example,  it would be of great interest  to know whether the interdependent 
reactions A and B represent the synthesis of nucleic  acid and protein respec- 
tively. 
SUMMARY 
A further analysis of the growth curve obtained in vitro  for influenza  virus 
in chorioaliantoic  membrane has been made using  the viral inhibitor p-fluoro- 
phenyialanine.  It has been found that p-fluorophenylalanine  is phase-specific, 
does not interfere with the initiation  of infection  but rather  acts during  the 
productive period of the infectious sequence.  The site of action of this fluoro- 
derivative has been described relative to the site of action of methoxinine.  By 
the  use of this  inhibitor  in combination with methoxinine,  it has been pos- 
sible to recognize two stages of development which were not discernible  from 
the usual growth curve. In a multicellular culture these two reactions, A and 
B, occur for the most part simultaneously, during  the latent and productive 
periods.  Reaction A is inhibited by methoxln~ue,  but not by fluorophenyiala- 
nine.  It begins  early in the latent period and can proceed independent of re- 
action B. Reaction B  is inhibited by fluorophenylalanine,  but not by meth- 
oxinine, and it cannot proceed unless reaction A is proceeding or has operated 
for some prior interval. 
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